WHO ICTRP trial

A clinical trial to examine the immunomodulatory effect of Triphala in Upper…

CTRI/2022/08/045079 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2022/08/045079
Public title A clinical trial to examine the immunomodulatory effect of Triphala in Upper Respiratory Tract Illness in adults
Scientific title A Randomized Placebo Controlled clinical trial to examine the immunomodulatory effect of Triphala in Recurrent Upper Respiratory Tract Illness in adults
Primary sponsor CSIRCIMAP
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 3
Countries India
Conditions Health Condition 1: J069- Acute upper respiratory infection,unspecified
Registration date Aug 30, 2022
Target size 60
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations